🔎 Trials Near Me

Home › Restless Legs › NCT06481176

Blood Changes After Exercise in Restless Legs Syndrome

Recruiting

Proteomic Response to Exercise in Adults With Restless Legs Syndrome

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* age 18 years or older;
* diagnosis of RLS;
* presence of moderate-to-severe RLS (IRLS score\>15);
* currently untreated RLS;
* being non-active defined as not engaging in regular activity (30 minutes accumulated per day) on more than 2 days of the week during the previous six months;
* ability to walk without assistance (does not use a cane/walker/wheelchair for mobility;
* willing to complete outcome measures and complete the exercise program

Exclusion Criteria:

* present with a condition that can mimic RLS or cause secondary RLS (e.g., iron deficiency anemia, radiculopathy, peripheral edema, peripheral neuropathy, diabetes);
* are at moderate or high risk for undertaking strenuous or maximal exercise

About the study

The goal of this clinical trial is to learn how exercise changes molecules in the blood in people with restless legs syndrome (RLS) to better understand the cause(s) of RLS. The main questions the investigators aim to answer are:

How does long-term exercise change proteins in the blood?

How does a single exercise session change proteins in the blood?

The investigators will compare long-term exercise to no exercise to see if the changes in proteins are specific to exercise.

Participants will complete an exercise test and provide blood samples before and after the exercise test. Participants will be randomized (like the flip of a coin) in to either the exercise or no-exercise group for 12 weeks and then complete the exercise test and blood samples again at the end.

What is being tested

Sponsor: Stanford University · Participants: 30 · Started: Oct 21, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06481176

Locations in the U.S.

CaliforniaStanford University, Stanford

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.